<DOC>
	<DOCNO>NCT00319774</DOCNO>
	<brief_summary>Volume overload contribute significantly pathogenesis hypertension hemodialysis patient . The Hemocontrol ( HC ) system ( Gambro ) , automatically adjust ultrafiltration rate dialysate conductivity accord blood volume variation dialysis , suggest improve hemodynamic tolerance thus facilitate fluid removal . This randomize controlled trial design compare use HC standard hemodialysis test hypothesis use HC system may lower home blood pressure comparison standard hemodialysis primary endpoint . Secondary endpoint variation percentage dialysis session require nurse ’ intervention intra-dialytic hypotension change health-related quality life HD patient .</brief_summary>
	<brief_title>Hemocontrol Blood Pressure Control Dialysis Patients</brief_title>
	<detailed_description>Hypertension common problem patient undergo chronic maintenance hemodialysis ( HD ) report prevalence 50 90 % [ Hörl , 2002 ] . As major risk factor cardiovascular disease , hypertension contributes high rate morbidity mortality ESRD patient [ Foley , 1996 ; Port , 1999 ] . For majority dialysis patient , volume overload ( VO ) play major role pathogenesis hypertension [ Fishbane , 1996 ; Rahman , 2000 ; Ventura , 1997 ] remove excess volume often normalize blood pressure [ Fishbane , 1996 ] . Unfortunately , correct VO frequently prove difficult hemodynamic instability HD session . As much 20 50 % dialysis patient present symptom intradialytic hypotension ( IDH ) [ Santoro , 2002 ] . IDH increase nursing work load negatively affect efficacy dialysis quality life HD patient . Different measure use avoid IDH , limitation salt water intake , avoidance antihypertensive medication dialysis , utilization low temperature dialysate , model ultrafiltration and/or dialysate conductivity . These measure often generate mixed result . The Hemocontrol ( HC ) biofeedback system ( Gambro® ) report reduce hemodynamic instability hypotensive episode hemodialysis [ Basile , 2001 ; Begin , 2002 ; Ronco , 2000 ; Santoro , 1994 ; Santoro , 1998 ; Santoro , 2002 ; Wolkotte , 2002 ] . The HC system consist fully integrate biofeedback system monitor regulate blood volume contraction hemodialysis software-driven adjustment ultrafiltration rate dialysate conductivity . By improve hemodynamic tolerance dialysis , use HC system suggest facilitate fluid removal correction VO , lead improve control hypertension . The present randomized control trial design test hypothesis use HC system would lower home BP comparison standard hemodialysis primary endpoint . Secondary endpoint variation percentage HD session require nurse ’ intervention change health-related quality life HD patient .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>18 year old chronic hemodialysis renal replacement therapy &gt; 3 month least 3 dialysis session 9 hour therapy weekly willing measure blood pressure home able sign inform consent anticipate change renal replacement therapy anticipate transfer another center plan renal transplantation enrollment another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2003</verification_date>
	<keyword>End-stage renal disease</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Hypotension</keyword>
	<keyword>Blood volume</keyword>
	<keyword>Hypervolemia</keyword>
	<keyword>Quality life</keyword>
	<keyword>Biofeedback system</keyword>
</DOC>